DrAid™ Chest X-ray is an imaging diagnostic software developed by VinBrain, using AI algorithms to classify and prioritize abnormal cases in chest X-rays, with high accuracy of up to 91%.
The software successfully supports the assessment of patients with chest X-rays that have characteristics suggestive of pneumothorax. In addition, this product developed from AI technology also integrates the ChatGPT tool to help doctors consult medical information from ChatGPT for free “all-in-one” on the interface, without using other platforms such as Google, creating comprehensive, accurate and effective medical reports.
Mr. Truong Quoc Hung, General Director of VinBrain at the cooperation announcement event in the US. Photo: VinBrain
DrAid™ Chest X-ray was approved by the US Food and Drug Administration (FDA) in September 2022. In less than a year since FDA approval, the software has achieved the first commercial agreement for the V1 Diagnostic Imaging product in the US market.
Specifically, DrAid™ Chest X-ray was officially put into use at Nutex Health Inc. Hospital System in the US, through a software provision agreement under the Software as a Service (SaaS) model.
Nutex Health Inc. is a 19-hospital system in 8 states in the US, focusing on emergency and primary care. After nearly 90 days of testing, DrAid™ has been recognized by Nutex Health physicians and executives for its positive impact, especially in the diagnostic radiology pathway of the Emergency Department.
Dr. Tom Vo, Chairman of the Board of Directors and CEO of Nutex Health Inc., highly appreciated DrAid™ Chest X-ray and said that this AI assistant helps increase the level of confidence in diagnosing difficult and emergency cases of doctors, when time plays a decisive role in the patient's life.
This is considered an important step forward for VinBrain on the path to bringing Vietnamese AI technology to the world's most demanding market.
In addition to DrAid™ Chest X-ray, VinBrain has also just launched the DrAid™ CT Liver Cancer cancer diagnosis software. This is an AI technology application platform that helps quickly and accurately identify abnormal lesions on the liver.
Source
Comment (0)